Tissue-specific RNA-Seq in human evoked inflammation identifies blood and adipose LincRNA signatures of cardiometabolic diseases

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 4, 2014, Pages 902-912

  Liu, Yichuan ^a   Ferguson, Jane F ^a   Xue, Chenyi ^a   Ballantyne, Rachel L ^a   Silverman, Ian M ^a   Gosai, Sager J ^a   Serfecz, Jacquelyn ^a   Morley, Michael P ^a   Gregory, Brian D ^a   Li, Mingyao ^a   Reilly, Muredach P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

genomics; lincRNA; RNA sequence

Indexed keywords

LIPOPOLYSACCHARIDE; LONG UNTRANSLATED RNA; NICOTINIC ACID; TRANSCRIPTOME;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EVOKED RESPONSE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LIPOPOLYSACCHARIDE-INDUCED ENDOTOXEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MIDDLE AGED; MODULATION; MONOCYTE; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA SEQUENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE LEVEL; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; YOUNG ADULT;

GENOMICS; LINCRNA; RNA SEQUENCE;

ADIPOCYTES; ADULT; BINDING SITES; CASE-CONTROL STUDIES; CELLS, CULTURED; ENDOTOXEMIA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENOME-WIDE ASSOCIATION STUDY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; METABOLIC SYNDROME X; MONOCYTES; OBESITY; REPRODUCIBILITY OF RESULTS; RNA, LONG NONCODING; SEQUENCE ANALYSIS, RNA; SUBCUTANEOUS FAT; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84897397472     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.303123     Document Type: Article

References (43)

1. Yang J, Manolio TA, Pasquale LR, et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet. 2011;43:519-525.
2. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for tran-scriptomics. Nat Rev Genet. 2009;10:57-63.
3. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008;456:470-476.
4. Consortium EP, Dunham I, Kundaje A, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57-74
5. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775-1789.
6. Hangauer MJ, Vaughn IW, McManus MT. Pervasive transcription of the human genome produces thousands of previously unidentifed long inter-genic noncoding RNAs. PLoS Genet. 2013;9:e1003569.
7. Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154:26-46.
8. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specifc subclasses. Genes Dev. 2011;25:1915-1927.
9. Penny GD, Kay GF, Sheardown SA, Rastan S, Brockdorff N. Requirement for Xist in X chromosome inactivation. Nature. 1996;379:131-137.
10. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E, Chang HY. Long noncoding RNA as modular scaffold of histone modifcation complexes. Science. 2010;329:689-693.
11. Bertani S, Sauer S, Bolotin E, Sauer F. The noncoding RNA Mistral activates Hoxa6 and Hoxa7 expression and stem cell differentiation by recruiting MLL1 to chromatin. Mol Cell. 2011;43:1040-1046.
12. Yap KL, Li S, Muñoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou MM. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcrip-tional silencing of INK4a. Mol Cell. 2010;38:662-674.
13. Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, Hall LL, Byron M, Monks B, Henry-Bezy M, Lawrence JB, O'Neill LA, Moore MJ, Caffrey DR, Fitzgerald KA. A long noncoding RNA mediates both activation and repression of immune response genes. Science. 2013;341:789-792.
14. Rapicavoli NA, Qu K, Zhang J, Mikhail M, Laberge RM, Chang HY. A mammalian pseudogene lncRNA at the interface of infammation and anti-infammatory therapeutics. Elife. 2013;2:e00762.
15. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321:280-287.
16. Calvano SE, Xiao W, Richards DR, et al.; Infammation and Host Response to Injury, Large Scale Collaborative Research Program. A network-based analysis of systemic infammation in humans. Nature. 2005;437:1032-1037.
17. Hudgins LC, Parker TS, Levine DM, Gordon BR, Saal SD, Jiang XC, Seidman CE, Tremaroli JD, Lai J, Rubin AL. A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res. 2003;44:1489-1498.
18. McGillicuddy FC, de la Llera Moya M, Hinkle CC, Joshi MR, Chiquoine EH, Billheimer JT, Rothblat GH, Reilly MP. Infammation impairs reverse cholesterol transport in vivo. Circulation. 2009;119:1135-1145.
19. Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, Tabita-Martinez J, Sellers KF, Rickels MR, Reilly MP. Experimental endotoxemia induces adipose infammation and insulin resistance in humans. Diabetes. 2010;59:172-181.
20. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab. 2000;85:3770-3778.
21. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-369.
22. Sarwar N, Butterworth AS, Freitag DF, et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-Analysis of 82 studies. Lancet. 2012;379:1205-1213
23. Van Cromphaut SJ, Vanhorebeek I, Van den Berghe G. Glucose metabolism and insulin resistance in sepsis. Curr Pharm Des. 2008;14:1887-1899.
24. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque pheno-type in mice defcient in apolipoprotein E. Proc Natl Acad Sci USA. 2004;101:10679-10684.
25. Shah R, Lu Y, Hinkle CC, McGillicuddy FC, Kim R, Hannenhalli S, Cappola TP, Heffron S, Wang X, Mehta NN, Putt M, Reilly MP. Gene profling of human adipose tissue during evoked infammation in vivo. Diabetes. 2009;58:2211-2219.
26. Ferguson JF, Patel PN, Shah RY, Mulvey CK, Gadi R, Nijjar PS, Usman HM, Mehta NN, Shah R, Master SR, Propert KJ, Reilly MP. Race and gender variation in response to evoked infammation. J Transl Med. 2013;11:63.
27. Liu Y, Ferguson JF, Xue C, Silverman IM, Gregory B, Reilly MP, Li M. Evaluating the impact of sequencing depth on transcriptome profling in human adipose. PLoS One. 2013;8:e66883.
28. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L. Transcript assembly and quantifcation by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511-515.
29. Cobb JP, Mindrinos MN, Miller-Graziano C, et al.; Infammation and Host Response to Injury Large-Scale Collaborative Research Program. Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci USA. 2005;102:4801-4806.
30. Haimovich B, Zhang Z, Calvano JE, Calvano SE, Kumar A, Macor MA, Corbett S, Coyle SM, Lowry SF. Cellular metabolic regulators: novel indicators of low-grade infammation in humans [published online ahead of print June 28, 2013]. Ann Surg. doi: 10.1097/SLA.0b013e31829a4352. http://jour-nals.lww.com/ annalsofsurgery/Abstract/publishahead/Cellular-Metabolic- Regulators-Novel- Indicators-of.98380.aspx. Accessed February 12, 2014.
31. Siepel A, Bejerano G, Pedersen JS, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005;15:1034-1050.
32. Matys V, Kel-Margoulis OV, Fricke E, et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 2006;34(Database issue):D108-D110.
33. Grant CE, Bailey TL, Noble WS. FIMO: scanning for occurrences of a given motif. Bioinformatics. 2011;27:1017-1018.
34. Lauc G, Huffman JE, Pucic M, et al. Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet. 2013;9:e1003225.
35. Gieger C, Radhakrishnan A, Cvejic A, et al. New gene functions in mega-karyopoiesis and platelet formation. Nature. 2011;480:201-208.
36. Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, Mohler ER, Reilly MP, Berger JS. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-Analysis. J Thromb Haemost. 2010;8:148-156.
37. Desch KC, Ozel AB, Siemieniak D, et al. Linkage analysis identifes a locus for plasma von Willebrand factor undetected by genome-wide association. Proc Natl Acad Sci USA. 2013;110:588-593.
38. Holdt LM, Hoffmann S, Sass K, et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet. 2013;9:e1003588.
39. Reilly MP, Li M, He J, et al.; Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium. Identifcation of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet. 2011;377:383-392.
40. Zhang H, Mooney CJ, Reilly MP. ABO blood groups and cardiovascular diseases. Int J Vasc Med. 2012;2012:641917.
41. Lauc G, Essaf A, Huffman JE, et al. Genomics meets glycomics-the frst GWAS study of human N-Glycome identifes HNF1α as a master regulator of plasma protein fucosylation. PLoS Genet. 2010;6:e1001256.
42. Sadler JE. von Willebrand factor: two sides of a coin. J Thromb Haemost. 2005; 3: 1702-1709.
43. Ishii N, Ozaki K, Sato H, Mizuno H, Saito S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, Saito S, Nakamura Y, Tanaka T. Identifcation of a novel non-coding RNA, MIAT, that confers risk of myo-cardial infarction. J Hum Genet. 2006;51:1087-1099.